149 related articles for article (PubMed ID: 36830164)
1. Implementation of MRSA Nasal Swabs as an Antimicrobial Stewardship Intervention to Decrease Anti-MRSA Therapy in COVID-19 Infection.
DeKerlegand A; Johnston E; Mellor B; Schrack MR; O'Neal C
Antibiotics (Basel); 2023 Jan; 12(2):. PubMed ID: 36830164
[TBL] [Abstract][Full Text] [Related]
2. Evaluating Methicillin-Resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Screening as a Tool for Antimicrobial Stewardship.
Bono K; Caceda JA; Zhai M; Horng H; Goldstein C; Sifri Z; Cennimo D; Glass NE
J Surg Res; 2023 Mar; 283():1047-1052. PubMed ID: 36914995
[TBL] [Abstract][Full Text] [Related]
3. Duration of Gram-negative antibiotic therapy in patients with pneumonia prior to and after the implementation of MRSA nasal swabs, an antimicrobial stewardship tool.
Troyer BS; Shigle AJ; Kovacic Scherrer N
J Antimicrob Chemother; 2022 Aug; 77(9):2557-2560. PubMed ID: 35733340
[TBL] [Abstract][Full Text] [Related]
4. Impact of a Pharmacist-driven Methicillin-resistant Staphylococcus aureus Polymerase Chain Reaction Nasal Swab Protocol on the De-escalation of Empiric Vancomycin in Patients with Pneumonia in a Rural Healthcare Setting.
Dadzie P; Dietrich T; Ashurst J
Cureus; 2019 Dec; 11(12):e6378. PubMed ID: 31938656
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of Anti-Methicillin-Resistant
Pelham M; Ganter M; Eudy J; Anderson DT
Pharmacy (Basel); 2023 May; 11(3):. PubMed ID: 37218963
[TBL] [Abstract][Full Text] [Related]
6. MRSA nasal swab PCR to de-escalate antibiotics in the emergency department.
Sindelar MA; Zepeski AE; Lawler BJ; Johnston SD; Faine BA
Am J Emerg Med; 2022 May; 55():133-137. PubMed ID: 35313228
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of methicillin-resistant staphylococcus aureus nasal swab in patients with COVID-19 pneumonia and secondary bacterial pneumonia.
Rowe AS; Hawkins B; McClam MD; Winters S; Balatow PB; Ryan M
Diagn Microbiol Infect Dis; 2024 Feb; 108(2):116134. PubMed ID: 37988933
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of methicillin-resistant Staphylococcus aureus (MRSA) nasal swab PCR assay for MRSA pneumonia.
Dangerfield B; Chung A; Webb B; Seville MT
Antimicrob Agents Chemother; 2014; 58(2):859-64. PubMed ID: 24277023
[TBL] [Abstract][Full Text] [Related]
9. Predictive Value of the Methicillin-Resistant
Stodghill J; Finnigan A; Newcomb AB; Lita E; Liu C; Teicher E
Surg Infect (Larchmt); 2021 Nov; 22(9):889-893. PubMed ID: 33872057
[No Abstract] [Full Text] [Related]
10. The Role of Negative Methicillin-Resistant Staphylococcus aureus Nasal Surveillance Swabs in Predicting the Need for Empiric Vancomycin Therapy in Intensive Care Unit Patients.
Chotiprasitsakul D; Tamma PD; Gadala A; Cosgrove SE
Infect Control Hosp Epidemiol; 2018 Mar; 39(3):290-296. PubMed ID: 29374504
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review of the Clinical Utility of Methicillin-Resistant Staphylococcus aureus (MRSA) Nasal Screening for MRSA Pneumonia.
Smith MN; Brotherton AL; Lusardi K; Tan CA; Hammond DA
Ann Pharmacother; 2019 Jun; 53(6):627-638. PubMed ID: 30600697
[TBL] [Abstract][Full Text] [Related]
12. Sensitivity and Specificity of prior Methicillin-Resistant
Wadle J; Wall GC; Smith HS
J Res Pharm Pract; 2020; 9(4):208-211. PubMed ID: 33912504
[TBL] [Abstract][Full Text] [Related]
13. Nasal Methicillin-Resistant Staphylococcus aureus (MRSA) PCR Testing Reduces the Duration of MRSA-Targeted Therapy in Patients with Suspected MRSA Pneumonia.
Baby N; Faust AC; Smith T; Sheperd LA; Knoll L; Goodman EL
Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137813
[TBL] [Abstract][Full Text] [Related]
14. A trial of discontinuation of empiric vancomycin therapy in patients with suspected methicillin-resistant Staphylococcus aureus health care-associated pneumonia.
Boyce JM; Pop OF; Abreu-Lanfranco O; Hung WY; Fisher A; Karjoo A; Thompson B; Protopapas Z
Antimicrob Agents Chemother; 2013 Mar; 57(3):1163-8. PubMed ID: 23254432
[TBL] [Abstract][Full Text] [Related]
15. Clinical utility of negative methicillin-resistant Staphylococcus aureus (MRSA) nasal surveillance swabs in skin and skin structure infections.
Burgoon R; Weeda E; Mediwala KN; Raux BR
Am J Infect Control; 2022 Aug; 50(8):941-946. PubMed ID: 34958856
[TBL] [Abstract][Full Text] [Related]
16. Clinical Utility of Methicillin-Resistant Staphylococcus aureus Nasal Screening for Antimicrobial Stewardship: A Review of Current Literature.
Carr AL; Daley MJ; Givens Merkel K; Rose DT
Pharmacotherapy; 2018 Dec; 38(12):1216-1228. PubMed ID: 30300441
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the negative predictive value of methicillin-resistant
Perreault SK; Binks B; McManus DS; Topal JE
Infect Control Hosp Epidemiol; 2021 Jul; 42(7):853-856. PubMed ID: 33228818
[TBL] [Abstract][Full Text] [Related]
18. Impact of a Pharmacist-Driven MRSA Nasal PCR Protocol on Pneumonia Therapy.
Pham SN; Sturm AC; Jacoby JS; Egwuatu NE; Dumkow LE
Hosp Pharm; 2021 Aug; 56(4):221-227. PubMed ID: 34381253
[No Abstract] [Full Text] [Related]
19. Evaluation of the Negative Predictive Value of Methicillin-Resistant
Tai CH; Liu WL; Pan SC; Ku SC; Lin FJ; Wu CC
Infect Drug Resist; 2022; 15():1259-1266. PubMed ID: 35355623
[TBL] [Abstract][Full Text] [Related]
20. Swab Testing to Optimize Pneumonia treatment with empiric Vancomycin (STOP-Vanc): study protocol for a randomized controlled trial.
Freiberg JA; Siemann JK; Qian ET; Ereshefsky BJ; Hennessy C; Stollings JL; Rali TM; Harrell FE; Gatto CL; Rice TW; Nelson GE
Res Sq; 2024 Jun; ():. PubMed ID: 38947088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
